He, J <br/><br/>
Cardiometabolic risks during anabolic hormone supplementation in older men.  [electronic resource] 

 -  Obesity (Silver Spring, Md.)  May 2013 
 - 968-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1930-739X 
<br/><br/><label>Standard No.: </label>10.1002/oby.20081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--blood<br/>Adipose Tissue--metabolism<br/>Aged<br/>Aged, 80 and over<br/>Aging<br/>Anabolic Agents--adverse effects<br/>Blood Pressure--drug effects<br/>Body Composition--drug effects<br/>Body Fluid Compartments--metabolism<br/>Body Mass Index<br/>Cardiovascular Diseases--etiology<br/>Cholesterol, HDL--blood<br/>Dietary Supplements--adverse effects<br/>Double-Blind Method<br/>Hormone Replacement Therapy--adverse effects<br/>Human Growth Hormone--adverse effects<br/>Humans<br/>Insulin Resistance<br/>Male<br/>Multivariate Analysis<br/>Risk Factors<br/>Testosterone--adverse effects<br/>Triglycerides--blood